Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL".
Press Release May 26 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aurobindo Pharma
- Press Release Mar 30 2023
- Press Release Mar 08 2023
- Press Release Feb 07 2023
- Press Release (Revised) Jan 04 2023
- Press Release Dec 27 2022
Later from Aurobindo Pharma
- Press Release May 27 2023
- Press Release Jun 23 2023
- Press Release Jul 04 2023
- Press Release Jul 12 2023
- Press Release Jul 25 2023
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma